Weiss Multi-Strategy Advisers’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,002
| Closed | -$235K | – | 634 |
|
|
2022
Q1 | $235K | Sell |
2,002
-3,017
| -60% | -$354K | 0.01% | 596 |
|
|
2021
Q4 | $675K | Buy |
+5,019
| New | +$675K | 0.02% | 506 |
|
|
2021
Q3 | – | Sell |
-16,793
| Closed | -$2.21M | – | 646 |
|
|
2021
Q2 | $2.21M | Buy |
16,793
+9,809
| +140% | +$1.29M | 0.05% | 377 |
|
|
2021
Q1 | $900K | Buy |
6,984
+966
| +16% | +$124K | 0.02% | 473 |
|
|
2020
Q4 | $1M | Sell |
6,018
-4,145
| -41% | -$692K | 0.02% | 453 |
|
|
2020
Q3 | $1.57M | Buy |
10,163
+114
| +1% | +$17.6K | 0.04% | 359 |
|
|
2020
Q2 | $1.49M | Buy |
10,049
+5,234
| +109% | +$774K | 0.04% | 352 |
|
|
2020
Q1 | $542K | Sell |
4,815
-185
| -4% | -$20.8K | 0.02% | 325 |
|
|
2019
Q4 | $696K | Buy |
+5,000
| New | +$696K | 0.01% | 447 |
|
|
2015
Q2 | – | Sell |
-22,000
| Closed | -$382K | – | 383 |
|
|
2015
Q1 | $382K | Buy |
+22,000
| New | +$382K | 0.02% | 347 |
|